Evidence map›Paper›PMID 39184355›Full record

ReviewBioMed research international2024

Ideal Living Skin Equivalents, From Old Technologies and Models to Advanced Ones: The Prospects for an Integrated Approach.

Andrei Riabinin, Maria Pankratova, Olga Rogovaya, Ekaterina Vorotelyak, Vasiliy Terskikh, Andrey Vasiliev

Abstract readReview
In one paragraph

Review in BioMed research international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrei RiabininDepartment of Cell Biology Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia.ORCID https://orcid.org/0000-0002-7337-1166
Maria PankratovaDepartment of Cell Biology Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia.
Olga RogovayaDepartment of Cell Biology Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia.
Ekaterina VorotelyakDepartment of Cell Biology Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia.
Vasiliy TerskikhDepartment of Cell Biology Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia.
Andrey VasilievDepartment of Cell Biology Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of technologies for the generation and transplantation of living skin equivalents (LSEs) is a significant area of translational medicine. Such functional equivalents can be used to model and study the morphogenesis of the skin and its derivatives, to test drugs, and to improve the healing of chronic wounds, burns, and other skin injuries. The evolution of LSEs over the past 50 years has demonstrated the leap in technology and quality and the shift from classical full-thickness LSEs to principled new models, including modification of classical models and skin organoids with skin derived from human-induced pluripotent stem cells (iPSCs) (hiPSCs). Modern methods and approaches make it possible to create LSEs that successfully mimic native skin, including derivatives such as hair follicles (HFs), sebaceous and sweat glands, blood vessels, melanocytes, and nerve cells. New technologies such as 3D and 4D bioprinting, microfluidic systems, and genetic modification enable achievement of new goals, cost reductions, and the scaled-up production of LSEs.

Indexed as

Induced Pluripotent Stem CellsSkinTissue EngineeringBioprintingHumansModels, BiologicalOrganoidsSkin, ArtificialWound Healing

Identifiers

PMID39184355
PMCPMC11343635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.